Harvard Men's Health Watch

What’s new with the shingles vaccine

Shingrix offers more protection than its predecessor. A new vaccine to protect against shingles could offer almost double the protection for older adults compared with the one currently in use. The original shingles vaccine, Zostavax, which was issued in 2006, reduces the risk of shingles by an average of 51%, but it becomes less effective as people age. It has a success rate of 70% for people ages 55 to 59, but…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In